Summary
SNAP-8 is a cosmetic peptide marketed to reduce expression lines by mimicking part of the SNAP-25 protein. The idea is to interfere with the protein complex nerves use to release acetylcholine, a gentler topical cousin of what botulinum toxin does. Published independent evidence is limited and comes mostly from the parent peptide, Argireline.
Structure
- E1
- E2
- M3
- Q4
- R5
- R6
- A7
- D8
HydrophobicGly / ProPolarBasic (+)Acidic (−)
Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2. An extended version of acetyl hexapeptide-3 (Argireline), mimicking the N-terminus of the SNAP-25 protein.
How it works
By competing with SNAP-25 for a place in the SNARE complex, the peptide is proposed to weaken vesicle fusion and reduce muscle contraction. Whether enough penetrates skin to reach nerve endings is debated.
Research use cases
Areas where SNAP-8 has been studied. Inclusion here does not mean it works for that purpose.
- Topical anti-wrinkle formulations
What the research found
Parent peptide (Argireline)
The original study of acetyl hexapeptide-3 reported inhibition of neurotransmitter release in cell models and a reduction in wrinkle depth in a small group of volunteers.1
Safety and open questions
Topical use is generally well tolerated. Not intended for injection.
Regulatory status
Cosmetic ingredient. Not a drug.
Status was accurate when this page was last reviewed on October 26, 2026. Regulations change; check with the relevant authority before relying on it.
SNAP-8: common questions
Is SNAP-8 like Botox?
It targets the same machinery in theory, but as a topical cosmetic its effect is far weaker and less certain. It does not paralyze muscles.
Is SNAP-8 approved for human use?
Cosmetic ingredient. Not a drug.
References
- Blanes-Mira C, Clemente J, Jodas G, et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science.
Links open a PubMed search for the exact title, or the original source where one is given.